amt-101
Recombinant proteinexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2019 (NCT04224857)
Timeline
Indications
Mechanism of action
- Interleukin-10Supplementation
IL10 supplementation
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04741087 | Phase 2 | Feb 5, 2021 | Applied Molecular Transport |
| NCT05372939 | Phase 2 | Feb 5, 2021 | Applied Molecular Transport |
| NCT04583358 | Phase 2 | Aug 26, 2020 | Applied Molecular Transport |
| NCT04224857 | Phase 1 | Apr 1, 2019 | Applied Molecular Transport |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Applied Molecular Transport | For profit | 4 | 4 | 2 | 2019 |
1 organizations
Page 1 / 1